Intal, Alexa .
HRN: 22-41-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/31/2022
01/06/2023
IV
28mg
Q24
Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes